Study of JMT202 for people with high triglycerides
Part of Hormones & metabolism clinical trials.
This trial tests a new injectable drug, JMT202, for people with high triglycerides (a type of fat in the blood). The goal is to see if it safely lowers triglycerides and may reduce heart risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your triglycerides are between 300 and 1000 mg/dL (about 3.4 to 11.3 mmol/L).
- You have a body mass index (BMI) between 24 and 40.
- You either are already on a stable dose of cholesterol-lowering medication, or you haven't taken any for at least 28 days before screening.
- You must be willing to keep your usual diet, exercise, and lifestyle throughout the study.
- You and your partner must use effective birth control during and for 6 months after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This study tests a new medicine called MAR001 in people with high triglycerides and remnant cholesterol, which are types of fats in the blood. It aims to see if the medicine can improve these levels while you stick to your usual diet and medications.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This trial tests a new medicine called ION775 to help lower very high triglyceride levels in the blood. Triglycerides are a type of fat, and having too much can increase heart disease risk. The study will check if ION775 is safe and actually works when added to your regular cholesterol medications.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.